1. Home
  2. PKBK vs GOSS Comparison

PKBK vs GOSS Comparison

Compare PKBK & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parke Bancorp Inc.

PKBK

Parke Bancorp Inc.

N/A

Current Price

$25.32

Market Cap

269.2M

Sector

Finance

ML Signal

N/A

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

N/A

Current Price

$3.56

Market Cap

726.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PKBK
GOSS
Founded
1999
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.2M
726.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PKBK
GOSS
Price
$25.32
$3.56
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.60
AVG Volume (30 Days)
31.4K
3.2M
Earning Date
01-23-2026
11-05-2025
Dividend Yield
2.83%
N/A
EPS Growth
21.56
N/A
EPS
2.83
N/A
Revenue
$71,766,000.00
$44,051,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.41
P/E Ratio
$8.97
N/A
Revenue Growth
13.64
N/A
52 Week Low
$16.94
$0.76
52 Week High
$25.55
$3.87

Technical Indicators

Market Signals
Indicator
PKBK
GOSS
Relative Strength Index (RSI) 80.07 61.72
Support Level $23.72 $3.53
Resistance Level $24.11 $3.87
Average True Range (ATR) 0.50 0.23
MACD 0.16 0.00
Stochastic Oscillator 84.58 64.80

Price Performance

Historical Comparison
PKBK
GOSS

About PKBK Parke Bancorp Inc.

Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: